Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05593653
PHASE4

Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes

Sponsor: Brigham and Women's Hospital

View on ClinicalTrials.gov

Summary

The aim of this study is to determine if suvorexant can help treat the severity of insomnia in midlife women who are pre-diabetic.

Official title: Treating Insomnia and Improving Glycemic Control in Midlife Women With Insomnia and Pre-diabetes

Key Details

Gender

FEMALE

Age Range

40 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

61

Start Date

2023-01-06

Completion Date

2025-12-31

Last Updated

2025-07-25

Healthy Volunteers

No

Interventions

DRUG

Suvorexant

20mg taken at bedtime for 4 weeks

DRUG

Placebo

placebo taken at bedtime for 4 weeks

Locations (1)

Brigham and Women's Hospital

Boston, Massachusetts, United States